Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancer.

Cancer discovery
2013
https://researcherprofiles.org/profile/1170623
23658296
Chen R, Sweet-Cordero EA